Found: 6
Select item for more details and to access through your institution.
Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly.
- Published in:
- Journal of the Endocrine Society, 2020, v. 4, n. 12, p. 1, doi. 10.1210/jendso/bvaa138
- By:
- Publication type:
- Article
Erratum. Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care 2024;47:770–781.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Atypical Diabetes: What Have We Learned and What Does the Future Hold?
- Published in:
- Diabetes Care, 2024, v. 47, n. 5, p. 770, doi. 10.2337/dci23-0038
- By:
- Publication type:
- Article
1656-P: FGF-21 Receptor Variants Demonstrate Severe Insulin Resistance in a Mouse Model of Insulin Mediated Pseudoacromegaly.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1656-P
- By:
- Publication type:
- Article
85-LB: A Phase 1b/2 Clinical Trial of Dantrolene Sodium in Patients with Wolfram Syndrome.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-85-LB
- By:
- Publication type:
- Article
26-OR: Digenic FGFR1/KLB Variants Associated with Endocrine Specific FGF-21 Signaling Defects and Extreme Insulin Resistance.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-26-OR
- By:
- Publication type:
- Article